Skip to main content

Advertisement

Log in

Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Studies have suggested that cadmium (Cd) may be involved in the etiology of nonalcoholic fatty liver disease (NAFLD), but available data in human is sparse.

Aims

We aimed to examine Cd exposure in young adulthood in relation to prevalent NAFLD in midlife among American adults.

Methods

This study included 2446 participants from the Coronary Artery Risk Development in Young Adults study with toenail Cd measurement at exam year 2 (baseline) and computed tomography quantification of liver fat at exam year 25. Toenail Cd concentrations were considered as a reliable marker of long-term exposure. NAFLD was defined if liver attenuation < 51 Hounsfield units after excluding other possible causes of liver fat. Multivariable-adjusted logistic regression models were used to estimate the odds ratio of NAFLD by Cd exposure.

Results

Median toenail Cd concentration was 8.2 ppb (inter-quartile range 4.3–18.6 ppb). After 23 years from baseline, 580 participants with prevalent NAFLD (24% prevalence) in midlife were identified. Compared with individuals in the lowest quartile, those in the highest quartile of toenail Cd had a significantly higher odds of NAFLD (OR: 1.43, 95% CI: 1.02, 1.99, P for trend: 0.04) after adjustment for demographics, socioeconomics, major lifestyle factors, and baseline levels of body mass index, lipids, and fasting insulin. The association was not significantly modified by race, sex, BMI, or smoking status at baseline.

Conclusions

Toenail Cd concentration was associated with a higher odds of prevalent NAFLD23 years later in life in this cohort of US general population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Goh GB, McCullough AJ. Natural history of nonalcoholic fatty liver disease. Dig Dis Sci. 2016;61:1226–1233

    Article  CAS  Google Scholar 

  2. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84

    Article  Google Scholar 

  3. Arciello M, Gori M, Maggio R, Barbaro B, Tarocchi M, Galli A et al. Environmental pollution: a tangible risk for nafld pathogenesis. Int J Mol Sci. 2013;14:22052–22066

    Article  Google Scholar 

  4. Sun C, Fan JG, Qiao L. Potential epigenetic mechanism in non-alcoholic fatty liver disease. Int J Mol Sci. 2015;16:5161–5179

    Article  CAS  Google Scholar 

  5. Zhang X, Ji X, Wang Q, Li JZ. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (nafld). Protein Cell. 2018;9:164–177

    Article  CAS  Google Scholar 

  6. Frediani JK, Naioti EA, Vos MB, Figueroa J, Marsit CJ, Welsh JA. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among US adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014. Environ Health. 2018;17:6

    Article  Google Scholar 

  7. Lin YC, Lian IB, Kor CT, Chang CC, Su PY, Chang WT et al. Association between soil heavy metals and fatty liver disease in men in Taiwan: a cross sectional study. BMJ Open. 2017;7:e014215

    Article  Google Scholar 

  8. Zhai H, Chen C, Wang N, Chen Y, Nie X, Han B et al. Blood lead level is associated with non-alcoholic fatty liver disease in the yangtze river delta region of china in the context of rapid urbanization. Environ Health. 2017;16:93

    Article  Google Scholar 

  9. Rahimzadeh MR. Cadmium toxicity and treatment: An update. Caspian J Intern Med. 2017;8:135–145

    Google Scholar 

  10. Zhang H, Reynolds M. Cadmium exposure in living organisms: a short review. Sci Total Environ. 2019;678:761–767

    Article  CAS  Google Scholar 

  11. Satarug S. Long-term exposure to cadmium in food and cigarette smoke, liver effects and hepatocellular carcinom. Current Drug Metabolism. 2012;13:257–271

    Article  CAS  Google Scholar 

  12. Zhang L, Huang Y, Zhu Y, Yu Z, Shao M, Luo Y. Identification and characterization of cadmium-related genes in liver carcinoma. Biol Trace Elem Res. 2018;182:238–247

    Article  CAS  Google Scholar 

  13. Baba H, Tsuneyama K, Yazaki M, Nagata K, Minamisaka T, Tsuda T et al. The liver in itai-itai disease (chronic cadmium poisoning): Pathological features and metallothionein expression. Mod Pathol. 2013;26:1228–1234

    Article  CAS  Google Scholar 

  14. Tinkov AA, Filippini T, Ajsuvakova OP, Skalnaya MG, Aaseth J, Bjorklund G et al. Cadmium and atherosclerosis: a review of toxicological mechanisms and a meta-analysis of epidemiologic studies. Environ Res. 2018;162:240–260

    Article  CAS  Google Scholar 

  15. Schwartz GG, D. Il’yasova, . PHD2 and Anastasia Ivanova, PHD3. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care. 2003;26:468–470

    Article  CAS  Google Scholar 

  16. Tinkov AA, Filippini T, Ajsuvakova OP, Aaseth J, Gluhcheva YG, Ivanova JM et al. The role of cadmium in obesity and diabetes. Sci Total Environ. 2017;601–602:741–755

    Article  Google Scholar 

  17. Chen Y, Xu X, Zeng Z, Lin X, Qin Q, Huo X. Blood lead and cadmium levels associated with hematological and hepatic functions in patients from an e-waste-polluted area. Chemosphere. 2019;220:531–538

    Article  CAS  Google Scholar 

  18. Matovic V, Buha A, Ethukic-Cosic D, Bulat Z. Insight into the oxidative stress induced by lead and/or cadmium in blood, liver and kidneys. Food Chem Toxicol. 2015;78:130–140

    Article  CAS  Google Scholar 

  19. Renugadevi J, Prabu SM. Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp Toxicol Pathol. 2010;62:171–181

    Article  CAS  Google Scholar 

  20. Go YM, Sutliff RL, Chandler JD, Khalidur R, Kang BY, Anania FA et al. Low-dose cadmium causes metabolic and genetic dysregulation associated with fatty liver disease in mice. Toxicol Sci. 2015;147:524–534

    Article  CAS  Google Scholar 

  21. Hyder O, Chung M, Cosgrove D, Herman JM, Li Z, Firoozmand A et al. Cadmium exposure and liver disease among us adults. J Gastrointest Surg. 2013;17:1265–1273

    Article  Google Scholar 

  22. Friedman GD, Cutter GR, Donahue RP. Cardia study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41:1105–1116

    Article  CAS  Google Scholar 

  23. Yang K, Xun P, Carnethon M, Carson AP, Lu L, Zhu J et al. Low to moderate toenail arsenic levels in young adulthood and incidence of diabetes later in life: findings from the cardia trace element study. Environ Res. 2019;171:321–327

    Article  CAS  Google Scholar 

  24. VanWagner LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, Carr JJ, Lima JA et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology. 2015;62:773–783

    Article  CAS  Google Scholar 

  25. Zeb I, Li D, Nasir K, Katz R, Larijani VN, Budoff MJ. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol. 2012;19:811–818

    Article  Google Scholar 

  26. VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ et al. Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: the cardia cohort study. Liver Int. 2018;38:706–714

    Article  Google Scholar 

  27. Hahn DRJJLP. Validity and reliability of short physical activity history: CARDIA and the Minnesota heart health program. J Cardiopulm Rehabil. 1989;9:448–459

    Article  Google Scholar 

  28. Ruiz-Hernandez A, Navas-Acien A, Pastor-Barriuso R, Crainiceanu CM, Redon J, Guallar E et al. Declining exposures to lead and cadmium contribute to explaining the reduction of cardiovascular mortality in the us population, 1988–2004. Int J Epidemiol. 2017;46:1903–1912

    Article  Google Scholar 

  29. Lee BK, Kim Y. Association of blood cadmium level with metabolic syndrome after adjustment for confounding by serum ferritin and other factors: 2008–2012 Korean national health and nutrition examination survey. Biol Trace Elem Res. 2016;171:6–16

    Article  CAS  Google Scholar 

  30. Kim JY, Kim SJ, Bae MA, Kim JR, Cho KH. Cadmium exposure exacerbates severe hyperlipidemia and fatty liver changes in zebrafish via impairment of high-density lipoproteins functionality. Toxicol In Vitro. 2018;47:249–258

    Article  CAS  Google Scholar 

  31. Kang MY, Cho SH, Lim YH, Seo JC, Hong YC. Effects of environmental cadmium exposure on liver function in adults. Occup Environ Med. 2013;70:268–273

    Article  CAS  Google Scholar 

  32. Wilcosky TC. Criteria for selecting and evaluating markers. In: Hulka BS, Wilcosky TC, Grifth JD, eds. New York, NY: Oxford University Press; 1990; 28–55.

    Google Scholar 

  33. Hunter D. Biochemical Indicators of Dietary Information. New York, NY: Oxford University Press; 1998.

    Google Scholar 

  34. Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2019;69:564–568

    Article  Google Scholar 

  35. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B et al. Nonalcoholic fatty liver disease in lean individuals in the united states. Medicine (Baltimore). 2012;91:319–327

    Article  Google Scholar 

  36. He K. Trace elements in nails as biomarkers in clinical research. Eur J Clin Invest. 2011;41:98–102

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We appreciate the investigators and the staff of the CARDIA study for valuable contributions.

Funding

This study was partially supported by grants from the NIH (R01HL081572 and R01DK116603). Dr. Van Wagner is support by the NHBLI (K23HL136891). The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by a few contracts from the National Heart, Lung, and Blood Institute (NHLBI), including HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I and HHSN268201800007I.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuijun Zhang.

Ethics declarations

Conflict of interest

No potential conflicts of interest relevant to this article were reported.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Chen, C., Lu, L. et al. Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife. Dig Dis Sci 67, 689–696 (2022). https://doi.org/10.1007/s10620-021-06869-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-021-06869-8

Keywords

Navigation